
Daniel C. Gamett
Examiner (ID: 4072, Phone: (571)272-1853 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647 |
| Total Applications | 1224 |
| Issued Applications | 721 |
| Pending Applications | 97 |
| Abandoned Applications | 422 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16282634
[patent_doc_number] => 20200276236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => REGULATORY MACROPHAGES FOR TREATING ANGIOPATHIES
[patent_app_type] => utility
[patent_app_number] => 16/647121
[patent_app_country] => US
[patent_app_date] => 2018-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647121 | Regulatory macrophages for treating angiopathies | Sep 11, 2018 | Issued |
Array
(
[id] => 14072323
[patent_doc_number] => 20190085049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => Pulsed Introduction of Low-Dose RANKL as a Therapy for Diet-Induced Atherosclerosis
[patent_app_type] => utility
[patent_app_number] => 16/126821
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16126821
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/126821 | Pulsed introduction of low-dose RANKL as a therapy for diet-induced atherosclerosis | Sep 9, 2018 | Issued |
Array
(
[id] => 14102275
[patent_doc_number] => 20190092813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/125213
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125213
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/125213 | Immunogenic WT-1 peptides and methods of use thereof | Sep 6, 2018 | Issued |
Array
(
[id] => 14016455
[patent_doc_number] => 20190070221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Methods to Mobilize Tissue Resident Cells for Adoptive T Cell Therapy
[patent_app_type] => utility
[patent_app_number] => 16/123261
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123261
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123261 | Methods to mobilize tissue resident cells for adoptive t cell therapy | Sep 5, 2018 | Issued |
Array
(
[id] => 14581301
[patent_doc_number] => 20190218259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => COMPOSITIONS AND METHODS FOR BROWN FAT INDUCTION AND ACTIVITY USING FNDC5
[patent_app_type] => utility
[patent_app_number] => 16/121211
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121211
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/121211 | Compositions and methods for brown fat induction and activity using FNDC5 | Sep 3, 2018 | Issued |
Array
(
[id] => 13987095
[patent_doc_number] => 20190062705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => METHODS FOR THE PRODUCTION OF THERAPEUTIC, DIAGNOSTIC, OR RESEARCH ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/118090
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16118090
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/118090 | Methods for the production of therapeutic, diagnostic, or research antibodies | Aug 29, 2018 | Issued |
Array
(
[id] => 14102399
[patent_doc_number] => 20190092875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => DEPLETING TUMOR-SPECIFIC TREGS
[patent_app_type] => utility
[patent_app_number] => 16/116067
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/116067 | DEPLETING TUMOR-SPECIFIC TREGS | Aug 28, 2018 | Abandoned |
Array
(
[id] => 13982651
[patent_doc_number] => 20190060483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => PREPARATION OF THERAPEUTIC EXOSOMES USING MEMBRANE PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/112547
[patent_app_country] => US
[patent_app_date] => 2018-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16112547
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/112547 | Preparation of therapeutic exosomes using membrane proteins | Aug 23, 2018 | Issued |
Array
(
[id] => 15980553
[patent_doc_number] => 10670597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Methods and kits for monitoring membranous nephropathy
[patent_app_type] => utility
[patent_app_number] => 16/106141
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 16776
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106141
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/106141 | Methods and kits for monitoring membranous nephropathy | Aug 20, 2018 | Issued |
Array
(
[id] => 13493091
[patent_doc_number] => 20180298088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/012395
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16012395
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/012395 | COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY | Jun 18, 2018 | Abandoned |
Array
(
[id] => 13618661
[patent_doc_number] => 20180360882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => Perispinal Perfusion by Administration of T regulatory Cells Alone or in Combination with Angiogenic Cell Therapies
[patent_app_type] => utility
[patent_app_number] => 16/009982
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16009982
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/009982 | Perispinal perfusion by administration of T regulatory cells alone or in combination with angiogenic cell therapies | Jun 14, 2018 | Issued |
Array
(
[id] => 13590023
[patent_doc_number] => 20180346560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => METHOD FOR MODULATING APPETITE
[patent_app_type] => utility
[patent_app_number] => 16/004519
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16004519
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/004519 | METHOD FOR MODULATING APPETITE | Jun 10, 2018 | Abandoned |
Array
(
[id] => 15738415
[patent_doc_number] => 20200108095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => UTILIZING THE INNATE IMMUNE SYSTEM TO DELIVER THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/615997
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615997
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615997 | UTILIZING THE INNATE IMMUNE SYSTEM TO DELIVER THERAPEUTIC AGENTS | May 28, 2018 | Abandoned |
Array
(
[id] => 15144979
[patent_doc_number] => 20190350967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => COMPOSITIONS FOR TREATMENT OF ARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 15/981057
[patent_app_country] => US
[patent_app_date] => 2018-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981057
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/981057 | Compositions for treatment of arthritis | May 15, 2018 | Issued |
Array
(
[id] => 17183822
[patent_doc_number] => 20210330707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => HIGHLY ACTIVE NK CELL AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/612091
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8895
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612091
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612091 | Highly active NK cell and use thereof | May 10, 2018 | Issued |
Array
(
[id] => 18384681
[patent_doc_number] => 11655453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Expansion of gd T cells, compositions, and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/610398
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 61
[patent_no_of_words] => 33314
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610398
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610398 | Expansion of gd T cells, compositions, and methods of use thereof | May 2, 2018 | Issued |
Array
(
[id] => 13578761
[patent_doc_number] => 20180340929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => TREATMENT OF INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/964324
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964324
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/964324 | TREATMENT OF INFLAMMATORY DISEASES | Apr 26, 2018 | Abandoned |
Array
(
[id] => 13522111
[patent_doc_number] => 20180312598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => HUMAN TNFRSF25 ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 15/964770
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964770
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/964770 | Human TNFRSF25 antibody | Apr 26, 2018 | Issued |
Array
(
[id] => 13522113
[patent_doc_number] => 20180312599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => ANTI-TNFRSF25 ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 15/964775
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964775
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/964775 | Anti-TNFRSF25 antibodies | Apr 26, 2018 | Issued |
Array
(
[id] => 14134293
[patent_doc_number] => 20190101536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY
[patent_app_type] => utility
[patent_app_number] => 15/962988
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962988
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/962988 | CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY | Apr 24, 2018 | Abandoned |